Friday, April 14, 2017

FDA rejects drugmaker's much-anticipated arthritis pill

Already approved in Europe, the FDA wants to see additional information on baricitinib’s safety and more

From: http://www.cbsnews.com/news/fda-rejects-baricitinib-drugmaker-eli-lilly-much-anticipated-arthritis-pill-olumiant/

No comments:

Post a Comment